2023 Behavioral Neurology & Neuropsychiatry Reading List

Reading List

Please click below to access the 2023 Behavioral Neurology & Neuropsychiatry reading list.

2023 Behavioral Neurology & Neuropsychiatry Reading List »

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

Upon completion of this UCNS C-cert activity, participants will be able to:
  • More accurately diagnose the mood symptoms that can occur after deep brain stimulation and know the strategies to treat these symptoms
  • More accurately differentiate and diagnose parkinsonian conditions, namely Parkinson’s disease from dementia with Lewy bodies and progressive supranuclear palsy, leading to improved symptom management and patient and family counseling
  • More accurately diagnose the cognitive symptoms that emerge with white matter diseases
  • More quickly diagnose the neuropsychiatric and cognitive comorbidities in epilepsy


The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy

2023 C-cert Activity Planner Disclosures
All relevant financial relationships have been mitigated.

Behavioral Neurology & Neuropsychiatry Certification Examination Committee Contributors

Robin A. Hurley, MD, Chair, W.G. Hefner VA Medical Center
Disclosures: Chief of research at a VA hospital, that does have grants from DoD, VA, and multiple pharmaceutical companies with all grants to institution; employee of the Department of Veterans Affairs; immediate past president of the American Neuropsychiatric Association.

Kyle J. Steinman, MD, MAS, Vice Chair, University of Washington/Seattle Children's Hospital
Disclosures: Partner received NIH funding for research.

James R. Bateman, III, MD, MPH, Wake Forest Baptist Medical Center
Disclosures: Received honoraria for talks given at North Carolina Neurological Society and NC Area Health Education Center for Cherry Mental Health Hospital; receive research support through the NIH/NIA, Alzheimer’s Association, and Dementia Alliance of North Carolina.

Colin J. Harrington, MD, Rhode Island Hospital and Brown University Medical School
Disclosures: Nothing to disclose.

Jonathan H. Woodcock, MD, University of Colorado – Anschutz Medical Campus
Disclosures: Received reimbursement as medical expert and for providing treating physician reports and testimony to a number of law firms

Michael J. Schrift, DO, MA, University of Washington
Disclosures: Nothing to disclose.

Mandana Modirrousta, MD, PhD, St. Boniface Hospital, Winnipeg, MB, Canada
Disclosures: Received royalties from Amblyotech, Royalties owned by Brain Matters Inc.; Dr. Modirrousta is a 33% shareholder of Brain Matters.

Lindsey Gurin, MD, NYU Langone
Disclosures: Human Services Research Institute - consultant for TBI Behavioral Health Guide; Healthcare Quality Strategies Inc - physician peer reviewer; Editorial board member for NeuroRehabilitation journal.

Samantha K. Holden, MD, MS, University of Colorado School Medicine
Disclosures: Received research grant from the Michael J. Fox Foundation for Parkinson's Research; National Institute on Aging Center grant from Lewy Body Dementia Association; Honoraria from the American Academy of Neurology for serving as course faculty at annual meetings; American Academy of Neurology NeuroReady Initial Board Prep course through September 2022 then resigned from the committee.

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326